Single treatment for both Plasmodium vivax and Plasmodium falciparum malaria Permission received to conduct Phase III clinical trials for pediatric formulation Gurgaon, India,: Ranbaxy Laboratories Limited (Ranbaxy) today announced that the company has received approval from the Central Drugs Standard Control Organisation (CDSCO), Government of India to manufacture and market Synriam … [Read more...]
New Drug Synriam Approved to Treat Malaria in India
A new drug to treat malaria, Synriam, was launched in India by Ranbaxy Laboratories Limited. The drug will provide additional options for malaria treatment as traditional drugs become increasingly ineffective against the deadly malarial parasite because of acquired resistance to available medications. Taken as a tablet once a day for three days, Synriam may be more effective, cheaper, and have … [Read more...]